Inventor · disambiguated record
Graham Cotton
Also filed as: COTTON GRAHAM · COTTON GRAHAM JOHN
13 granted patents·14 pending applications·18 citations·filing 2002–2025
88Inventor score
Files withTLA TARGETED IMMUNOTHERAPIES AB8ALMAC DISCOVERY LTD4COTTON GRAHAM3ALMAC SCIENCES SCOTLAND LTD2ANDERSON DAVID WILLIAM1
Top patents by PatentIndex Score
27 records- 0191US10429385B2Treating conditions associated with sepsisTLA TARGETED IMMUNOTHERAPIES AB·Filed 2017·Granted Oct 1, 2019·3 cites·8 claims
- 0291US10401357B2Treating cancerTLA TARGETED IMMUNOTHERAPIES AB·Filed 2017·Granted Sep 3, 2019·3 cites·12 claims
- 0382US9726666B2Diagnosing and treating inflammatory diseasesTLA TARGETED IMMUNOTHERAPIES AB·Filed 2013·Granted Aug 8, 2017·2 cites·9 claims
- 0478US8877177B2Chemokine containing apheresis column and methods of useWINQVIST OLA·Filed 2009·Granted Nov 4, 2014·3 cites·21 claims
- 0574US2019361020A1Treating respiratory conditionsTLA TARGETED IMMUNOTHERAPIES AB·Filed 2019·Application pending·0 cites
- 0672US7622552B2Ligation methodALMAC SCIENCES SCOTLAND LTD·Filed 2004·Granted Nov 24, 2009·3 cites·20 claims
- 0770US10502736B2Treating multiple sclerosisTLA TARGETED IMMUNOTHERAPIES AB·Filed 2017·Granted Dec 10, 2019·0 cites·9 claims
- 0870US10451620B2Treating conditions associated with metabolic syndromeTLA TARGETED IMMUNOTHERAPIES AB·Filed 2017·Granted Oct 22, 2019·0 cites·9 claims
- 0970US10422800B2Treating respiratory conditionsTLA TARGETED IMMUNOTHERAPIES AB·Filed 2017·Granted Sep 24, 2019·0 cites·8 claims
- 1070US10408832B2Treating mental disordersTLA TARGETED IMMUNOTHERAPIES AB·Filed 2017·Granted Sep 10, 2019·0 cites·7 claims
- 1169US2025295767A1Ror1-specific antigen binding moleculesALMAC DISCOVERY LTD·Filed 2025·Application pending·0 cites
- 1256US2025375530A1Ror1/egfr bi-specific antigen binding moleculesALMAC DISCOVERY LTD·Filed 2023·Application pending·0 cites
- 1355US2006040319A1Multiple sensor-containing active modified polypeptides, preparation and uses thereofMUIR TOM·Filed 2004·Application pending·0 cites
- 1454US2004023409A1Site-specific labelling of proteins using acridone and quinacridone lifetime dyesFiled 2002·Application pending·0 cites
- 1553US12324837B2ROR1-specific antigen binding moleculesMCLEAN ESTELLE GRACE·Filed 2018·Granted Jun 10, 2025·0 cites·57 claims
- 1649US2025269051A1Ror1-specific variant antigen binding moleculesALMAC DISCOVERY LTD·Filed 2021·Application pending·0 cites
- 1747US2006051811A1Site-specific labelling of proteins using acridone and quinacridone lifetime dyesCOTTON GRAHAM·Filed 2003·Application pending·0 cites
- 1846US2014080162A1Fluorescence lifetime epigenetics assaysCOTTON GRAHAM·Filed 2012·Application pending·0 cites
- 1945US7557573B2NMR-based methods for detecting ligands, where the ligand or target are hyperpolarized and the NMR-spectrum is compared with a reference spectrum of the ligand or targetGE HEALTHCARE AS·Filed 2003·Granted Jul 7, 2009·3 cites·9 claims
- 2045US2004023408A1Site-specific labelling of proteins using cyanine dye reportersFiled 2002·Application pending·0 cites
- 2144US2007010673A1Purification meansCSS ALBACHEM LTD·Filed 2004·Application pending·0 cites
- 2241US2005239144A1Site-specific labelling of proteins using cyanine dye reportersCOTTON GRAHAM·Filed 2003·Application pending·0 cites
- 2339US2023241072A1Anthracycline derivativesALMAC DISCOVERY LTD·Filed 2020·Application pending·0 cites
- 2437US9127164B2Fluorescent dyes and uses thereofRAMAGE ROBERT·Filed 2006·Granted Sep 8, 2015·1 cites·28 claims
- 2534US2014349297A1Fluorescent dyes based on acridine and acridinium derivativesALMAC SCIENCES SCOTLAND LTD·Filed 2012·Application pending·0 cites
- 2633US2012128629A1Method of labelling interferons with pegROBERTS JENNIFER·Filed 2010·Application pending·0 cites
- 2729US8846864B2Purification tags of synthetic peptides and proteinsANDERSON DAVID WILLIAM·Filed 2011·Granted Sep 30, 2014·0 cites·15 claims
Join the waitlist — get patent alerts
Get an alert when Graham Cotton files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →